Neuland Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	3,550	1,319	875.75	454.16	50.91
Short-Term Investments	-	1,077	-	-	33.77
Cash & Short-Term Investments	3,550	2,396	875.75	454.16	84.68
Cash Growth	48.14%	173.61%	92.83%	436.31%	-4.76%
Accounts Receivable	5,414	3,162	3,760	3,687	2,380
Other Receivables	-	79.78	70.45	31.6	35.16
Receivables	5,414	3,242	3,830	3,719	2,415
Inventory	5,103	3,858	3,504	2,792	2,652
Prepaid Expenses	-	117.18	111.41	105.38	74.16
Other Current Assets	765.24	1,782	889.07	538.4	582.18
Total Current Assets	14,831	11,395	9,211	7,609	5,808
Property, Plant & Equipment	11,018	7,183	5,686	4,980	4,866
Long-Term Investments	19.82	15.29	12.79	5.25	4.97
Goodwill	2,795	2,795	2,795	2,795	2,795
Other Intangible Assets	62.66	48.54	24.58	13.01	21.2
Other Long-Term Assets	575.13	362.74	596.7	395.86	340.41
Total Assets	29,301	21,799	18,326	15,798	13,835
Accounts Payable	2,691	2,522	1,920	1,710	1,174
Accrued Expenses	23.08	841.95	1,060	626.39	451.21
Short-Term Debt	-	-	-	111.58	922.15
Current Portion of Long-Term Debt	356.66	452.83	375.86	361.07	344.84
Current Portion of Leases	49.64	25.1	36.79	30.92	26.46
Current Income Taxes Payable	181.56	0.89	0.81	104.02	-
Other Current Liabilities	3,800	814.07	883.53	1,446	713.08
Total Current Liabilities	7,102	4,657	4,277	4,390	3,632
Long-Term Debt	1,609	907.27	449.21	742.46	1,042
Long-Term Leases	996.95	186.18	92.03	38.48	69.4
Pension & Post-Retirement Benefits	-	23.72	36.54	70.08	86.92
Long-Term Deferred Tax Liabilities	689.64	728.22	604.39	582.99	566.99
Other Long-Term Liabilities	158.61	48.5	39.56	33.11	32.52
Total Liabilities	10,557	6,551	5,499	5,857	5,430
Common Stock	129.01	128.3	128.3	128.3	128.3
Additional Paid-In Capital	-	4,978	4,978	4,978	4,978
Retained Earnings	-	10,225	7,804	4,931	3,360
Comprehensive Income & Other	18,616	-83.24	-82.79	-96.38	-61.31
Shareholders' Equity	18,745	15,248	12,827	9,941	8,405
Total Liabilities & Equity	29,301	21,799	18,326	15,798	13,835
Total Debt	3,013	1,571	953.9	1,284	2,405
Net Cash (Debt)	536.93	824.76	-78.14	-830.34	-2,321
Net Cash Growth	-34.90%	-	-	-	-
Net Cash Per Share	41.85	64.28	-6.09	-64.72	-180.88
Filing Date Shares Outstanding	12.83	12.83	12.83	12.83	12.83
Total Common Shares Outstanding	12.83	12.83	12.83	12.83	12.83
Working Capital	7,729	6,738	4,934	3,219	2,176
Book Value Per Share	1460.99	1188.48	999.78	774.83	655.11
Tangible Book Value	15,887	12,405	10,008	7,133	5,589
Tangible Book Value Per Share	1238.29	966.88	780.04	555.99	435.64
Land	-	330.91	287.48	107.43	107.43
Buildings	-	2,342	2,049	1,820	1,722
Machinery	-	6,554	5,336	4,635	4,337
Construction In Progress	-	445.53	458.91	405.66	204.57

Source: S&P Global Market Intelligence. Standard template. Financial Sources.